Curaleaf Holdings (CURLF) Exchange Rate Effect (2021 - 2024)
Curaleaf Holdings (CURLF) posted quarterly Exchange Rate Effect of $1.9 million for Q4 2024, up 177.27% year-on-year from $671906.2 in Q1 2024, and up 199.89% on a QoQ basis from -$1.9 million in Q3 2024.
Curaleaf Holdings (CURLF) Exchange Rate Effect (2021 - 2024) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Exchange Rate Effect for 4 consecutive years, with $1.9 million the latest figure, recorded in Q4 2024.
- Quarterly Exchange Rate Effect rose 177.27% year-over-year to $1.9 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$1.0 million (up 40.91% YoY) and the FY2025 annual result came in at $478000.0, up 422.97% from the prior year.
- Exchange Rate Effect grew to $1.9 million in Q4 2024 per CURLF's latest filing, from -$1.9 million in the prior quarter.
- Over the last five years, Exchange Rate Effect for CURLF reached as high as $1.9 million in Q4 2024 and fell as low as -$2.9 million in Q2 2022.
- A 4-year average of -$664700.0 and a median of -$728000.0 in 2022 frame the typical range for Exchange Rate Effect.
- The largest YoY upside for Exchange Rate Effect was 334.41% in 2023 against a maximum downside of 1828.8% in 2023.
- Year by year, Exchange Rate Effect stood at $857000.0 in 2021, then slumped by 114.59% to -$125000.0 in 2022, then plunged by 1828.8% to -$2.4 million in 2023, then soared by 177.27% to $1.9 million in 2024.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered $1.9 million, -$1.9 million, and -$2.4 million for Q4 2024, Q3 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -17.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 17.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 7.01 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -4.20 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -5.00 Mn |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1.86 Mn |
| Dec 31, 2024 | 1.86 Mn |
| Sep 30, 2024 | -1.87 Mn |
| Sep 30, 2024 | -1.87 Mn |
| Dec 31, 2023 | -2.41 Mn |
| Dec 31, 2023 | -2.41 Mn |
| Sep 30, 2023 | 1.38 Mn |
| Sep 30, 2023 | 1.38 Mn |
| Dec 31, 2022 | -125,000.00 |
| Dec 31, 2022 | -125,000.00 |
| Sep 30, 2022 | -590,000.00 |
| Sep 30, 2022 | -590,000.00 |
| Jun 30, 2022 | -2.89 Mn |
| Jun 30, 2022 | -2.89 Mn |
| Mar 31, 2022 | -866,000.00 |
| Mar 31, 2022 | -866,000.00 |
| Dec 31, 2021 | 857,000.00 |
| Dec 31, 2021 | 857,000.00 |
| Sep 30, 2021 | -2.01 Mn |
| Sep 30, 2021 | -2.01 Mn |